Allotment of Equity Share Warrants pursuant to Preferential Issue under the provisions of Chapter V of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 and applicable provisions of Companies Act 2013 and the rules made thereunder, each as amended (the 'Preferential Issue') .
Venmax Drugs & Pharmaceuticals Ltd. Press Release Mar 21 2025
Filed with BSE · · 6 pages · English
Release
Venmax Drugs & Pharmaceuticals Ltd. on 6ix
Earlier from Venmax Drugs & Pharmaceuticals
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Feb 14 2025
- Integrated Filing (Financial)
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Feb 10 2025
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Feb 07 2025
Later from Venmax Drugs & Pharmaceuticals
- Closure of Trading Window
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Mar 28 2025
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Apr 09 2025
- Resignation Of Ms. Pratibha Jhawar From The Post Of Company Secretary & Compliance Officer
Follow Venmax Drugs & Pharmaceuticals into a list and get an email when it puts out news.
Follow Venmax Drugs & Pharmaceuticals